Beam Therapeutics Inc.

NASDAQ: BEAM · Real-Time Price · USD
17.64
0.12 (0.68%)
At close: Aug 14, 2025, 3:59 PM
17.72
0.45%
Pre-market: Aug 15, 2025, 04:09 AM EDT

Beam Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
281.97M 435.89M 232.77M 965.65M
Short-Term Investments
568.77M 753.98M 845.37M 405.65M
Long-Term Investments
n/a n/a 12.75M 12.75M
Other Long-Term Assets
9.4M 10.87M 1.93M 309.08M
Receivables
n/a n/a n/a 300M
Inventory
n/a n/a n/a -607.36M
Other Current Assets
27.41M 21.17M 14.76M n/a
Total Current Assets
878.15M 1.21B 1.09B 965.65M
Property-Plant & Equipment
216.28M 237.81M 234.13M 186.98M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
225.68M 248.67M 248.82M 508.81M
Total Assets
1.1B 1.46B 1.34B 1.47B
Account Payables
3.87M 1.62M 9.03M 7.47M
Deferred Revenue
108.86M 68.71M 135.97M 86.27M
Short-Term Debt
n/a n/a 1.85M 2.29M
Other Current Liabilities
37.78M 100.69M 49.09M 100.49M
Total Current Liabilities
182.07M 205.56M 223.59M 213.44M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
7.04M 3.02M 13.84M 37.17M
Total Long-Term Liabilities
188.21M 272.82M 384.64M 434.28M
Total Liabilities
370.28M 478.38M 608.24M 647.72M
Total Debt
161.43M 172.69M 179M 142.35M
Common Stock
836K 816K 712K 684K
Retained Earnings
-1.57B -1.19B -1.06B -768.27M
Comprehensive Income
679K 604K -2.43M -50K
Shareholders Equity
733.54M 981.33M 733.47M 826.74M
Total Investments
568.77M 753.98M 845.37M 405.65M